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Discussion of Analytic Methods 
 
This section discusses our analytic strategy for first estimating the impacts of the MTO 
mobility intervention on outcomes (intention to treat and treatment on the treated), and then 
discusses our quasi-experimental approach for estimating dose-response relationships between 
neighborhood disadvantage and health outcomes. 
 
A. Intention to treat 
 
We begin with simple comparisons of the average outcomes (diabetes, obesity, or 
neighborhood conditions) of adults assigned to different MTO groups, known as the intention to 
treat (ITT). Let Yi be some outcome of interest for program participant (i). We estimate a model 
using pooled data from all three MTO groups with Z consisting of two separate indicators for 
assignment to the low-poverty voucher and traditional voucher groups. We calculate the ITT 
effects as the two elements of 11 in equation (1) using ordinary least squares for continuous 
dependent variables and logistic regression for dichotomous dependent variables, conditioning 
on a set of (pre-random assignment) baseline characteristics (X), including dichotomous site 
indicators.
a
 For our logit models we present average marginal effects, which, as we demonstrate 
below, are quite similar from the marginal effects we obtain from using linear probability models 
for dichotomous dependent variables as a sensitivity analysis. All estimates in this paper are 
computed using sample weights.
b
 
 
(1) Yi = Zi 11 + Xiπ12 + e1i 
 
B. Treatment on the treated 
 
Our methodology for estimating the effects of treatment on the treated (TOT) comes from 
Angrist, Imbens and Rubin
2
 (hereafter AIR). Medical readers may be more familiar with the term 
                                                          
a
 These include (besides site) survey measures of the socio-demographic characteristics of household members, and 
survey reports about youth experiences in school such as expulsions or enrollment in gifted and talented classes.  In 
models where the outcome of interest comes from official arrest data, we also condition on a set of indicators for the 
number of pre-program arrests for violent, property, drug or other offenses. Because the distribution of pre-program 
characteristics should be balanced across treatment groups with random assignment, conditioning on these variables 
serves mainly to improve the precision of the treatment effect estimates. 
b
 The weights we use to analyze survey-reported outcomes have three components, described in detail in Orr
1
, 
Appendix B. The survey procedure attempted to contact a subsample of difficult-to-locate cases.  Sub-sample 
members receive greater weight since, in addition to themselves, they represent individuals whom we did not 
attempt to contact during the sub-sampling phase. Survey youth from large families receive greater weight since we 
randomly sampled two children per household so these youth represent a larger fraction of the study population. 
Weights are also used since the ratio of individuals randomly assigned to treatment groups was changed during the 
course of the demonstration to adjust in response to differences between projected and actual use of offered 
vouchers, and weighting avoids potential confounding of treatment group with calendar time effects. Individuals 
within treatment groups are weighted by their inverse probability of assignment to the group to account for changes 
in the random assignment ratios. Models for official arrest outcomes use only this last weighting component. 
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“complier average causal effect” (CACE) (see, for example, Jo3, Becque and White4, King et 
al.
5
, McNamee
6
). Estimates for both the TOT and CACE require the assumption that assignment 
to either of the MTO treatment groups does not have any effect on the health outcomes of those 
families that do not actually move with a MTO voucher, which is known in the statistics 
literature as the “exclusion restriction.” This assumption may not be literally true, since the 
counseling services and search assistance offered to treatment families may influence later 
mobility patterns or other youth behaviors even among families that do not relocate through 
MTO. The disappointment of searching but failing to find an apartment may also affect non-
movers in the treatment groups. If the effects of treatment-group assignment are substantially 
smaller for those who do not move through MTO compared to those who do (although not 
exactly zero as assumed in TOT estimation), our TOT estimates will approximate the effects of 
MTO moves on those who move through the MTO program. Readers should keep this 
assumption in mind when interpreting the TOT estimates presented in our tables. 
 
In the MTO application, the TOT and CACE should equal one another assuming the 
exclusion restriction is met. This can be illustrated using the framework from AIR, who define 
the study population into four groups on the basis of what Rubin
7,8
 calls “potential outcomes.” 
These four groups are as follows (from Table 1 of AIR p. 448): 
  
Compliers = those who would receive the “treatment” (in this application, move through 
MTO) if randomly assigned to one of the MTO treatment groups (the low-poverty 
voucher group or the traditional voucher group), but would not receive the treatment if 
assigned to the control group condition instead. 
 
Never-takers = people who would never receive the treatment (move through MTO) 
regardless of whether they are assigned to the treatment groups or to the control group. 
 
Defier = people who would receive the treatment if they are assigned to the control 
group, but not if they are assigned to the treatment group. Since our “treatment” is 
defined as “use of a MTO voucher,” and only families assigned to the treatment groups 
had access to MTO vouchers, there are no defiers in MTO given the study’s design. 
 
Always-takers = people who would receive the treatment regardless of whether they are 
assigned to the treatment groups or to the control group. Since MTO vouchers are only 
made available to those assigned to the treatment groups, there are no always-takers in 
MTO given the study’s design. 
 
The never-takers, defiers and always-takers together constitute the group of “non-
compliers.” Since there cannot be any defiers or always-takers in MTO given the way the 
experiment was designed, the non-compliers are equal to the never-takers. The TOT effect – or 
the effect of actually moving with a MTO voucher – is defined under the AIR framework as the 
difference in average outcomes that the compliers would experience if they are assigned to the 
treatment group versus the average outcomes the compliers would experience if they are 
assigned to the control group (see AIR, p. 449). This is also the definition of the CACE. 
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Estimating the TOT effect on the compliers is complicated in practice by the fact that we 
can observe who is a complier versus never-taker within the treatment group, but we cannot tell 
which specific individuals are compliers within the control group (that is, would have used an 
MTO voucher if they had been assigned to the treatment group instead). By virtue of random 
assignment, we know that the share of people who are compliers (PC) and never-takers (PN) 
should be the same across randomly-assigned groups. This means that we can estimate the share 
of people who would be compliers in the control group from looking at the share of actual 
compliers in the treatment group. Note also that because there are no defiers or always-takers in 
MTO given the experiment’s design, it is then the case that PC+PN=1. The ITT effect is a 
weighted average of the effect on the compliers (TC) and never-takers (TN), or: 
 
(2) ITT  = PC*TC + PN*TN 
 
If we are willing to assume that random assignment to the treatment group has no effect 
on the never-takers, then TN=0, and the ITT effect is then: 
 
(3) ITT  = PC*TC + PN*0 
= PC*TC  
 
Rearranging terms in the equation above yields: 
 
(4) TC = ITT / PC 
 
In words, the effect of the MTO intervention on the compliers (the TOT effect) is equal 
to the ITT effect divided by the share of the study sample that consists of compliers. A different 
way to think of the TOT calculation comes from noting that the denominator in equation (4) is 
basically the ITT effect of MTO treatment group assignment on the likelihood of moving 
through MTO, so that the TOT estimate is the ratio of two fully-experimental ITT estimates (the 
ITT for the health outcome of interest divided by the ITT effect on treatment rates). This TOT 
calculation does not compare compliers with non-compliers, since compliance status is not 
randomized. Indeed in Table 5 in this Supplementary Appendix below we show that observable 
baseline characteristics are systematically different for compliers and non-compliers within each 
of the two MTO treatment groups, which raises the possibility that unmeasured individual 
attributes that influence health may also differ systematically between compliers and non-
compliers as well. Equation (4) is the standard formula for calculating the TOT effect in a 
randomized experiment that has no defiers or always-takers; see also AIR (p. 449), Bloom
9
, and 
Angrist and Pischke
10
 (p. 164). In a model with no covariates this is equivalent to using two-
stage least squares (instrumental variables) to estimate TOT, using treatment group assignment 
as an instrumental variable for treatment take-up. The first stage uses linear regression to regress 
an indicator for using a MTO voucher against an indicator for assignment to one of the MTO 
treatment groups, together with the baseline variables shown in Table 1. The second stage uses 
linear regression to regress the health outcomes reported in row labels at left against the same 
baseline covariates plus the predicted value of using a MTO voucher from the first stage; the 
indicator for assignment to one of the MTO treatment groups serves as the instrumental variable 
excluded from the second stage regression (see AIR).  
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This standard TOT formula, together with the fact that 48% of those assigned to the low-
poverty voucher group and 63% of those assigned to the traditional voucher group use a MTO 
voucher, is the basis for our statement in the main text of the paper that the TOT effect for the 
low-poverty voucher is 2 times the ITT effect for that treatment, while the TOT effect for the 
traditional voucher is 1.5 times the ITT effect for that treatment. 
 
C. Dose-response model 
 
Also of interest is the relationship between health outcomes for MTO program 
participants and specific candidate mediating measures, such as census tract poverty rates, which 
we estimate using the instrumental variables (IV) approach from Kling et al..
 11
 Let M1 represent 
a measure of a candidate mediating mechanism through which MTO might affect health in a 
model in which there is only one mediator, while X represents the baseline control variables. The 
relationship between the candidate mediator(s) and health is summarized by the parameter(s) π51 
in outcome equation (5). 
 
(5) Yi = M1i π51 + Xiπ52 + e5i 
 
For purposes of estimation of equation (5) we view our measures of tract poverty rate as a 
summary measure of neighborhood economic disadvantage. Thus π51 should be viewed as the 
effect of moving to a neighborhood that has a lower poverty rate and other aspects of 
neighborhood economic disadvantage that co-vary with tract poverty rates.  
 
Ordinary least squares or logistic regression estimation of (5) may be biased by self-
selection of systematically different types of families into different types of neighborhoods. That 
is, families that wind up living in lower-poverty tracts may be systematically different from those 
who live in high-poverty areas in ways that are difficult to measure in a social science dataset 
and that also directly affect health outcomes. We build on the approach of Kling et al.
11
, and use 
interactions between dichotomous indicators for treatment group assignments (Z) and site 
indicators (S) as instrumental variables to isolate the experimentally-induced variation in some 
candidate mediating variable, M1, across MTO demonstration sites and groups, as in equation 
(6), where the main site effects are subsumed in X. In the second-stage equation (7) we replace 
M1 with the predicted value from the first stage equation, 1, and thus isolate the variation in the 
mediating measure across the MTO sample that is due just to variation across the demonstration 
sites in treatment effects on the mediator.  
 
(6) M1i = Zi*Si π61 + Xiπ62 + e6i 
(7) Yi = 1i π71 + Xiπ72 + e7i 
 
 The intuition behind this quasi-experimental instrumental variables (IV) design is to take 
advantage of the fact that in some sites, the MTO treatment may have generated relatively larger 
changes in census tract poverty rates than in other sites. The IV design asks whether the site and 
treatment group that experiences the relatively larger change in census tract poverty rates also 
show the most pronounced change in health outcomes. 
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 Our measure for M1 in Table 9 of this Supplementary Appendix is equal to the duration-
weighted average census tract poverty rate that families experience over the study period (from 
random assignment through 2008). Data on census tract poverty rates come from the 1990 
census, the 2000 census, and the 2005-2009 American Community Survey (ACS). We use linear 
interpolation to estimate census tract poverty rates between 1990 and 2000, and between 2000 
and the time of the ACS (which we assign to be 2007, the mid-point of the ACS data collection 
window). 
 
We also present results using as a measure for M1 the concentrated disadvantage index 
defined by Sampson et al.
12
, which is a weighted combination of census tract percent (1) poverty, 
(2) African-American, (3) on welfare (4) unemployed, (5) female-headed family households, and 
(6) under age 18, with loading factors from Sampson et al.
12 
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Discussion of Supplemental Tables 
 
Supplemental Table 1 presents descriptive statistics by treatment group for additional 
baseline characteristics that are not included in Table 1. Taking the 57 baseline characteristics 
shown in Table 1 and Supplemental Table 1, as a set the differences across treatment groups are 
not statistically significant.  
 
Supplemental Table 2 shows the association between the interventions and residential 
mobility and neighborhood characteristics. Specifically, the table shows intent-to-treat and 
treatment-on-treated estimates for Census tract poverty rates for the respondents’ addresses at 
baseline, 1 year after random assignment, 5 years after random assignment, and then 10-12 years 
after random assignment for each treatment group and its compliers. For each of these time 
periods, we have also included the percentile ranking and z-score based on the 2000 national 
distribution of census tracts to gain a better understanding of how poor these tracts are relative to 
the rest of the nation. Supplemental Table 2 also examines the respondent’s exposure to various 
Census tract characteristics by averaging these characteristics based on how long they lived in 
each tract. In addition, the table presents analyses of the respondent’s reports on their 
neighborhood’s collective efficacy, safety, friends with college degrees, and access to local 
health services. 
 
Supplemental Table 3 presents findings on our main outcomes (BMI ≥ 30, BMI ≥ 35, 
BMI ≥ 40, and HbA1c ≥ 6.5%) using three different estimation procedures: a) logistic 
regression, calculating TOT effects by dividing the ITT effect by each MTO treatment group’s 
compliance rate (share using a MTO housing voucher); b) linear regression, calculating the TOT 
by dividing the ITT by the treatment group’s compliance rate; and c) calculating treatment-on-
the-treated by using instrumental variables (IV) methods described above.  
 
Supplemental Table 4 and Supplemental Table 5 allow the reader to compare average 
health outcomes and baseline covariates for MTO compliers and non-compliers. The comparison 
of the average health outcomes for compliers and non-compliers is not informative about the 
effects of actually moving with a MTO housing voucher, because compliers and non-compliers 
represent two distinct (and self-selected) types of people. 
 
Suppose, for example, that the MTO program participants who would move if they were 
assigned into one of the experiment’s treatment groups (the compliers) had background factors 
that put them at elevated risk for adverse health outcomes compared to those people who would 
not move if assigned to the treatment group (non-compliers). In this case, a comparison of 
average health outcomes of the compliers versus the never-takers would confound the causal 
effect on health outcomes from actually moving through MTO with the effects on health 
outcomes from measured and unmeasured background factors that are systematically different 
for compliers versus non-compliers. Put differently, the systematic differences in other risk 
factors between compliers and non-compliers would help mask any beneficial effect of moving 
through MTO on health.  
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Indeed, Table 5 in this Supplementary Appendix makes clear that there are numerous 
statistically significant differences in baseline survey characteristics between compliers and 
never-takers within the two MTO treatment groups. A Wald test rejects the hypothesis that the 
baseline covariates are jointly insignificant in predicting the likelihood of using a MTO voucher, 
both for the low-poverty voucher group and the traditional voucher group (p<.001 in both 
samples). Our baseline surveys are not directly informative about whether the compliers have 
background factors that put them at elevated versus reduced risk for health problems compared 
to never-takers, given that the baseline surveys collected by HUD included very limited 
information about health or health-related risk and protective factors. But Supplemental Table1 
does make clear that compliers and non-compliers are systematically different types of people. 
 
Supplemental Table 6 examines what happens to the impact of the main health outcomes 
and Census tract characteristics when the sample is split by the adult respondent’s age at 
baseline: below 33 versus 33 and above. This sub-group analysis was suggested by a peer 
reviewer in response to an earlier draft of our submitted manuscript, and so is post hoc. Our test 
for whether there is a statistically significant difference in effects by baseline age comes from 
testing the coefficient for the interaction of an indicator for assignment to the treatment group 
and an interaction for being ages 33 and over, following the recommendation of Wang et al. 
(2007). 
 
Supplemental Table 7 shows the impact of the main health outcomes and Census tract 
characteristics when the sample is split by random assignment site. This sub-group analysis (as 
with those shown in Supplemental Table 6) was also suggested by a peer reviewer in response to 
an earlier draft of our submitted manuscript, and so is post hoc. Our test for whether MTO 
effects on health vary across demonstration sites comes from calculating an F-test for the joint 
significance of interactions for indicators for demonstration site and treatment assignment, which 
helps account for concerns about multiplicity in carrying out sub-group tests raised by Wang et 
al.
13 
 
Supplemental Table 8 presents baseline control group and city-characteristics by site, in 
order to gain a better understanding of cross-site differences.  The table presents household 
characteristics as well as city-level statistics on:  crime (in 1994), poverty (in 1990), and health 
(in 2002 and 2004).  
 
Supplemental Table 9 uses an instrumental variables approach to estimate the association 
between changes in neighborhood characteristics (census tract poverty rate and the concentrated 
disadvantage index
c
) and changes in BMI and HbA1c (≥6.5%).  The intuition behind this quasi-
experimental instrumental variables (IV) design is to take advantage of the fact that in some 
sites, the MTO treatment generated relatively larger changes in mediating measures than in 
others, and to use the sizes of these changes to estimate the causal effect of each mediator. (See 
discussion above). The table presents our estimates for coefficients π71 in equation (7) above, 
                                                          
c
 The concentrated disadvantage index is a weighted combination of census tract percent (1) poverty, (2) African-
American, (3) on welfare (4) unemployed, (5) female-headed families, and (6) under age 18, with loading factors 
determined by Sampson et al.
12 
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when the mediating measures (M1) are defined as tract poverty or tract concentrated 
disadvantage. 
 
The four different columns along the top of the Table represent the dependent variable 
(Y) in the regression. The columns represent the different mediating variables (M1) that are 
instrumented for one at a time, using interactions of MTO treatment group and demonstration 
site dummies. For example, the cell of the table in the first column, second row shows our 
instrumental variables estimate for the coefficient π71 from equation (7), derived by using two-
stage least squares to equations (6) and (7) above. The dependent variable in the second stage 
equation for this cell is an indicator for BMI above 35 kg/m
2
, and the mediating measure that is 
being instrumented for with site-group interactions (M1) is the family’s duration-weighted tract 
poverty rate for their addresses over the entire study period. The coefficient of 0.62 (in the 
second row and first column of the table) shown for the IV regression of a BMI above 35 kg/m
2 
on tract poverty can be interpreted as suggesting that decreasing the poverty rate of a tract from 
30 percent to 20 percent is associated with a 6.2 percentage point decrease in the subject’s 
likelihood of having a BMI above 35 kg/m
2 
(p<.01). 
 
The second column presents results from re-estimating equations (6) and (7) using two-
stage least squares, but now using the family’s tract poverty rate averaged over just the three 
years preceding the long-term survey (a measure of contemporaneous exposure to neighborhood 
poverty). The third column presents results from a separate two-stage least squares estimating of 
(6) and (7) using average tract poverty rates from baseline through the period three years before 
our long-term survey as the mediator of interest (a measure of lagged exposure to neighborhood 
poverty). The final column presents results using the duration-weighted average concentrated 
disadvantage index for families over the entire study period as the endogenous mediating 
measure of interest in the model. The results imply that going from the 75
th
 percentile in the 
MTO study sample for the concentrated disadvantage index value (2.05) to the 25
th
 percentile 
(1.30) is associated with a decline in the likelihood of BMI over 35 kg/m
2
 of 13.94 percentage 
points (i.e., -0.75 x 18.59). 
 
 We also estimated models that control for two endogenous explanatory variables at once, 
to examine non-linearities in the association between tract poverty or concentrated disadvantage 
with health outcomes, or to try to disentangle the influences of contemporaneous versus lagged 
exposure to poverty. Unfortunately, given the nature of the MTO research design, these estimates 
wound up being very imprecise and thus not very informative. 
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Supplemental Table 1. Additional Baseline Characteristics of Study Sample, by Randomized MTO Mobility Group  
   
Low-poverty housing voucher   Traditional housing voucher   Control 
   
(n = 1425) 
 
(n = 657) 
 
(n = 1104) 
           
   
No.
a
 (%)
a
 
 
No.
a
 (%)
a
 
 
No.
a
 (%)
a
 
Household Characteristics 
        
 
Female head of household 1327 (92.9) 
 
617 (95.6) 
 
1020 (93.8) 
 
Household member disabled 216 (14.6) 
 
111 (16.9) 
 
161 (14.9) 
 
Owns car 242 (18.6) 
 
115 (17.9) 
 
189 (16.5) 
 
No teens in household 871 (60.9) 
 
412 (61.5) 
 
706 (64.7) 
 
Household size 
        
  
Two 306 (22.5) 
 
150 (21.5) 
 
212 (19.0) 
  
Three 431 (30.2) 
 
197 (29.4) 
 
366 (33.3) 
  
Four 340 (23.3) 
 
155 (23.9) 
 
245 (22.4) 
  
Five or more 348 (24.0) 
 
155 (25.2) 
 
281 (25.2) 
Government Benefits 
        
 
Aid to Families with Dependent Children 1086 (76.4) 
 
486 (74.5) 
 
840 (76.9) 
 
Food Stamps 1165 (81.7) 
 
529 (81.7) 
 
898 (82.3) 
 
Women, Infants, and Children 505 (36.9) 
 
240 (37.7) 
 
397 (37.2) 
 
Medicaid 988 (72.1) 
 
477 (73.3) 
 
750 (71.2) 
Over 30 Minutes Away from the…       
 Grocery store 308 (21.3)  135 (22.4)  231 (21.1) 
 Doctor 587 (42.7)  297 (43.8)  479 (45.0) 
          
  
13 
 
Supplemental Table 1. continued                 
   
Low-poverty housing voucher   Traditional housing voucher   Control 
   
(n = 1425) 
 
(n = 657) 
 
(n = 1104) 
           
   
No.
a
 (%)
a
 
 
No.
a
 (%)
a
 
 
No.
a
 (%)
a
 
Neighborhood Characteristics 
b
 
        
 
Household member victimized in past 6 
months 602 (43.2) 
 
274 (41.5) 
 
443 (41.4) 
 
Streets very unsafe at night 692 (49.5) 
 
351 (52.2) 
 
562 (51.3) 
 
Very dissatisfied with neighborhood 668 (48.2) 
 
316 (48.2) 
 
490 (46.6) 
 
Very confident about finding new apartment 661 (48.0) 
 
333 (50.7) 
 
498 (45.6) 
 
Lived in neighborhood 5 or more years 832 (59.8) 
 
408 (61.5) 
 
633 (60.4) 
 
Moved more than 3 times in 5 years prior to 
baseline 127 (9.2) 
 
53 (9.2) 
 
121 (11.0) 
 
Previously applied for Section 8 553 (40.0) 
 
263 (38.1) 
 
478 (43.0) 
 
No family in neighborhood 887 (64.3) 
 
418 (61.1) 
 
703 (63.9) 
 
Chatted with neighbors at least once per week 747 (52.5) 
 
326 (48.7) 
 
598 (54.7) 
 
Very likely to tell neighbor about their child 
getting into trouble 775 (55.5) 
 
341 (51.7) 
 
617 (55.9) 
Primary or Secondary Reason for Moving was…       
 
To get away from drugs and gangs 1092 (78.6)  485 (75.5)  843 (77.8) 
Better schools for the children 676 (49.0)  353 (55.4)  502 (48.1) 
 To get a bigger or better apartment 625 (44.4)  280 (43.9)  509 (45.9) 
 To get a job 91 (6.3)  31 (5.0)  64 (7.0) 
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Supplemental Table 1. continued                 
   
Low-poverty housing voucher   Traditional housing voucher   Control 
   
(n = 1425) 
 
(n = 657) 
 
(n = 1104) 
   
No.
a
 (%)
a
 
 
No.
a
 (%)
a
 
 
No.
a
 (%)
a
 
Site 
        
 
Baltimore 196 (13.4) 
 
93 (14.2) 
 
152 (13.3) 
 
Boston 280 (20.2) 
 
133 (20.6) 
 
248 (20.4) 
 
Chicago 371 (20.4) 
 
107 (21.6) 
 
179 (20.7) 
 
Los Angeles 269 (23.0) 
 
135 (20.0) 
 
296 (22.1) 
 
New York 309 (23.0) 
 
189 (23.6) 
 
229 (23.5) 
Site/Randomization Cohort 
        
 
Baltimore, Cohort 1 164 (9.1) 
 
39 (9.2) 
 
101 (8.7) 
 
Baltimore, Cohort 2 32 (4.3) 
 
54 (4.9) 
 
51 (4.6) 
Boston, Cohort 1 173 (9.4) 42 (9.7) 105 (9.6) 
 Boston, Cohort 3 52 (7.7)  70 (7.9)  123 (7.7) 
 Boston, Cohort 7 55 (3.2)  21 (3.0)  20 (3.1) 
 Chicago, Cohort 1 200 (11.4)  51 (11.9)  118 (11.3) 
 Chicago, Cohort 3 133 (6.2)  25 (6.2)  42 (6.0) 
 Chicago, Cohort 8 38 (2.8)  31 (3.4)  19 (3.4) 
 Los Angeles, Cohort 1 107 (6.3)  19 (4.5)  66 (5.5) 
 Los Angeles, Cohort 4 134 (13.4)  82 (12.7)  190 (12.8) 
 Los Angeles, Cohort 11 28 (3.4)  34 (2.8)  40 (3.7) 
 New York, Cohort 1 115 (6.1)  25 (5.4)  73 (6.7) 
 New York, Cohort 5 166 (14.7)  149 (15.9)  133 (14.7) 
 New York, Cohort 9 9 (1.1)  11 (1.0)  15 (1.3) 
 New York, Cohort 10 19 (1.1)  4 (1.3)  8 (0.9) 
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Supplemental Table 1. continued                 
a
 No. unweighted. % calculated using sample weights to account for changes in random assignment ratios across randomization cohorts and for 
subsample interviewing. Sample is female adults with valid Body Mass Index (BMI) or valid glycosylated hemoglobin (HbA1c). An omnibus F-test 
fails to reject null hypothesis that the joint set of baseline characteristics reported in Table 1 and those above are the same across MTO random 
assignment groups (p-value for the low-poverty housing voucher vs. control comparison is p=.93; p-value for the traditional housing voucher vs. 
control comparison is p=.35). 
 The baseline head of household reported on the neighborhood characteristics listed here. 
  
Supplemental Table 2. Association between MTO Randomized Intervention and Neighborhood Conditions during Study Period and Relative to National Neighborhood Poverty 
Distribution 
a
 
    Low-poverty housing voucher vs. control group  Traditional housing voucher vs. control group 
 
Control 
Mean  
Intention to Treat 
[ITT]
b
 (95% CI)  
Treatment on the 
Treated 
[TOT]
c
  (95% CI)  
P 
Value  N  
Intention to Treat 
[ITT]
b
 (95% CI)  
Treatment on the  
Treated 
[TOT]
c
  (95% CI)  
P 
Value  N 
                              
Tract Poverty at Baseline 
d
 
Natural units (%)
e
 53.1  -0.37 (-1.23 to 0.50)  -0.76 (-2.55 to 1.03)  .41  2404  -0.37 (-1.55 to 0.81)  -0.60 (-2.52 to 1.31)  .54  1673 
Percentile ranking
 f
 96.2  -0.25 (-0.81 to 0.31)  -0.52 (-1.68 to 0.64)  .38  2404  0.01 (-0.69 to 0.71)  0.01 (-1.13 to 1.15)  .98  1673 
Z-score
 g
 3.2  -0.03 (-0.10 to 0.04)  -0.06 (-0.21 to 0.08)  .41  2404  -0.03 (-0.13 to 0.07)  -0.05 (-0.20 to 0.11)  .54  1673 
Tract Poverty 1 Year Post-Random Assignment 
Natural units (%)
e
 50.0  -17.06 (-18.57 to -15.56)  -35.21 (-38.32 to -32.11)  <.01  2404  -13.50 (-15.33 to -11.67)  -21.98 (-24.97 to -19.00)  <.01  1673 
Percentile ranking
 f
 94.6  -19.41 (-21.01 to -17.80)  -40.05 (-43.37 to -36.73)  <.01  2404  -7.17 (-8.69 to -5.65)  -11.68 (-14.15 to -9.20)  <.01  1673 
Z-score
 g
 2.9  -1.38 (-1.50 to -1.26)  -2.85 (-3.10 to -2.60)  <.01  2404  -1.09 (-1.24 to -0.95)  -1.78 (-2.02 to -1.54)  <.01  1673 
Tract Poverty 5 Years Post-Random Assignment 
Natural units (%)
e
 39.9  -9.78 (-11.25 to -8.31)  -20.19 (-23.22 to -17.16)  <.01  2404  -6.26 (-8.41 to -4.11)  -10.19 (-13.70 to -6.69)  <.01  1673 
Percentile ranking
 f
 89.3  -11.43 (-13.06 to -9.80)  -23.59 (-26.95 to -20.23)  <.01  2404  -3.71 (-5.81 to -1.61)  -6.04 (-9.47 to -2.62)  <.01  1673 
Z-score
 g
 2.1  -0.79 (-0.91 to -0.67)  -1.64 (-1.88 to -1.39)  <.01  2404  -0.51 (-0.68 to -0.33)  -0.83 (-1.11 to -0.54)  <.01  1673 
Tract Poverty 10-14 Years Post-Random Assignment 
Natural units (%)
e
 33.0  -4.86 (-6.23 to -3.48)  -10.02 (-12.86 to -7.19)  <.01  2404  -2.87 (-4.80 to -0.95)  -4.68 (-7.81 to -1.55)  <.01  1673 
Percentile ranking
 f
 83.5  -6.58 (-8.45 to -4.72)  -13.59 (-17.43 to -9.75)  <.01  2404  -2.20 (-4.77 to 0.37)  -3.59 (-7.77 to 0.60)  .09  1673 
Z-score
 g
 1.5  -0.39 (-0.51 to -0.28)  -0.81 (-1.04 to -0.58)  <.01  2404  -0.23 (-0.39 to -0.08)  -0.38 (-0.63 to -0.13)  <.01  1673 
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Supplemental Table 2. continued 
    Low-poverty housing voucher vs. control group  Traditional housing voucher vs. control group 
 
Control 
Mean  
Intention to Treat 
[ITT]
b
 (95% CI)  
Treatment on the Treated 
[TOT]
c
  (95% CI)  
P 
Value  N  
Intention to Treat 
[ITT]
b
 (95% CI)  
Treatment on the  
Treated 
[TOT]
c
  (95% CI)  
P 
Value  N 
                              
Average Census Tract Characteristics from Random Assignment through Long-Term Follow-up; percent tract that is: 
h
 
Poor 39.6  -9.14 (-10.26 to -8.02)  -18.87 (-21.17 to -16.56)  <.01  2404  -6.07 (-7.53 to -4.61)  -9.89 (-12.27 to -7.50)  <.01  1673 
Minority 88.0  -6.23 (-7.58 to -4.89)  -12.87 (-15.65 to -10.09)  <.01  2404  -0.99 (-2.88 to 0.90)  -1.61 (-4.68 to 1.46)  .30  1673 
Single female-
headed family 
households 54.3 
 
-7.95 (-9.08 to -6.82)  -16.40 (-18.73 to -14.07)  <.01  2404  -5.03 (-6.55 to -3.51)  -8.19 (-10.67 to -5.72)  <.01  1673 
College graduates 16.1  4.49 (3.68 to 5.30)  9.27 (7.60 to 10.94)  <.01  2404  1.41 (0.29 to 2.52)  2.29 (0.48 to 4.10)  .01  1673 
Collective Efficacy: Neighbors are Likely to Do Something about Kids Spraying Graffiti on Local Building 
i
 
Interim survey 
j
 54.0  10.61 (6.46 to 14.76)  22.80 (13.89 to 31.71)  <.01  2377  5.30 (0.53 to 10.07)  8.86 (0.88 to 16.84)  .03  1927 
Long-term survey 58.9  8.20 (4.20 to 12.21)  16.92 (8.65 to 25.18)  <.01  2516  0.80 (-5.16 to 6.76)  1.29 (-8.29 to 10.87)  .79  1752 
Safety: Respondent Feels Safe/Very Safe on Streets Near Home During the Day 
i
 
Interim survey 
j
 74.9  9.14 (5.77 to 12.52)  19.29 (12.16 to 26.41)  <.01  2482  8.95 (5.16 to 12.73)  14.93 (8.62 to 21.23)  <.01  2023 
Long-term survey 80.7  3.70 (0.52 to 6.87)  7.60 (1.08 to 14.12)  .02  2522  5.00 (0.50 to 9.50)  8.03 (0.81 to 15.26)  .03  1756 
Social Networks: Respondent has At Least One Friend who Graduated from College 
i
 
Interim survey 
j
 40.8  6.90 (2.63 to 11.17)  14.59 (5.56 to 23.62)  <.01  2414  4.55 (-0.22 to 9.33)  7.60 (-0.37 to 15.56)  .06  1963 
Long-term survey 53.4  6.90 (2.74 to 11.06)  14.11 (5.60 to 22.61)  <.01  2478  -2.11 (-8.33 to 4.11)  -3.39 (-13.37 to 6.60)  .51  1723 
Access to Local Health Services: Has a Place to Go for Routine Care (Excluding Emergency Room)
i
 
Interim survey 
j
 89.7  -1.35 (-4.13 to 1.43)  -2.85 (-8.73 to 3.02)  .34  2490  -0.21 (-3.15 to 2.73)  -0.35 (-5.26 to 4.56)  .89  2022 
Long-term survey 93.4  -1.36 (-3.49 to 0.77)  -2.80 (-7.17 to 1.58)  .21  2526  0.64 (-2.11 to 3.40)  1.04 (-3.39 to 5.46)  .65  1755 
                              
  
18 
 
Supplemental Table 2. continued 
a
 The analysis sample consists of female adults in MTO with valid Body Mass Index (BMI) or valid glycosylated hemoglobin (HbA1c) in the long-term follow-up data collection, 
and the analysis sample for the number of moves and census tract characteristics is further limited to those who have valid address data at baseline, year 1, year 5, and year 10. 
Census tract characteristics are as of the time when the MTO family lived in the tract, calculated by interpolating tract poverty values using data from the 1990 and 2000 decennial 
censuses and the 2005-09 American Community Survey. For the low-poverty voucher comparison, the number of observations denotes the total number of women included in the 
analyses from both the control and low-poverty voucher groups.  For the traditional voucher comparison, the number of observations denotes the total number of women included in 
the analyses from both the control and traditional voucher groups. 
b
 Intention to treat (ITT) estimates compare average outcomes of everyone assigned to treatment group with average outcomes of controls, adjusting for the set of baseline 
covariates shown in Table 1 and indicators for survey sample release and random assignment periods. Impacts calculated using linear regression. 
c
 Treatment on the Treated (TOT) estimate is intended to capture the change in the outcome/mediator associated with MTO-assisted moves among those who actually moved with 
MTO vouchers. It is estimated by dividing the treatment group's ITT effect by the share of the group that complies with the treatment, which is equivalent to using random 
assignment as an instrumental variable for treatment group compliance.  
d
 Baseline date ranged from 1994 to 1998. 
e
 Natural units are tract percent poverty. 
f
 Percentile ranking is based on the national distribution of tract poverty from the 2000 Census. 
g
 Z-score is the distance in standard deviations from the mean of the national tract poverty distribution from the 2000 Census.  
h
 Census tract characteristics are as of the time when the MTO family lived in the tract, calculated by interpolating tract poverty values using data from the 1990 and 2000 decennial 
censuses and the 2005-09 American Community Survey. Average duration-weighted census tract characteristics give more weight to tracts in which MTO families spent relatively 
more time during the study period. 
i
 Reported by MTO adults on the interim and long-term follow-up surveys, which occurred 4-7 and 10-15 years after random assignment. 
j
 The analysis sample for interim follow-up study (2002) measures use that study's sample and weights, limited to female adults and adjusting for the same set of covariates as the 
long-term survey measures. 
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Supplemental Table 3. Association between MTO Randomized Intervention and Main Health Outcomes - Robustness to Alternative Estimation Procedures 
a
 
    Low-poverty housing voucher vs. control group  Traditional housing voucher vs. control group 
  Control 
Prevalence 
(%) 
 
Intention to Treat 
[ITT]
b
 (95% CI) 
 Treatment on the 
Treated 
[TOT]
c
  (95% CI) 
 
P 
Value  N 
 
Intention to Treat 
[ITT]
b
 (95% CI)  
Treatment on the 
Treated 
[TOT]
c
  (95% CI) 
 
P 
Value  N 
Logistic regression, TOT calculated by rescaling ITT (main results from Table 3) 
c
                   
Body Mass Index (BMI) 
d 
                            
 BMI ≥ 30 kg/m2 58.6  -1.19 (-5.41 to 3.02)  -2.45 (-11.10 to 6.21)  .58  2508  -0.14 (-6.27 to 5.98)  -0.24 (-10.20 to 9.73)  .96  1747 
 BMI ≥ 35 kg/m2 35.5  -4.61 (-8.54 to -0.69)  -9.47 (-17.53 to -1.41)  .02  2508  -5.34 (-11.02 to 0.34)  -8.69 (-17.93 to 0.55)  .07  1747 
 BMI ≥ 40 kg/m2 17.7  -3.38 (-6.39 to -0.36)  -6.93 (-13.12 to -0.75)  .03  2508  -3.58 (-7.95 to 0.80)  -5.83 (-12.95 to 1.30)  .11  1747 
Glycosylated Hemoglobin (HbA1c) 
e
                           
 HbA1c ≥ 6.5% 20.0  -4.31 (-7.82 to -0.80)  -8.86 (-16.09 to -1.63)  .02  2092  -0.08 (-5.18 to 5.02)  -0.12 (-8.13 to 7.88)  .98  1516 
Linear regression, TOT calculated by rescaling ITT 
c
                   
Body Mass Index (BMI) 
d 
                            
 BMI  32.9  -0.64 (-1.33 to 0.05)  -1.32 (-2.73 to 0.10)  .07  2508  -0.43 (-1.53 to 0.68)  -0.69 (-2.48 to 1.10)  .45  1747 
 BMI ≥ 30 kg/m2 58.6  -1.19 (-5.43 to 3.05)  -2.45 (-11.15 to 6.25)  .58  2508  -0.18 (-6.36 to 6.01)  -0.29 (-10.35 to 9.78)  .96  1747 
 BMI ≥ 35 kg/m2 35.5  -4.65 (-8.65 to -0.65)  -9.55 (-17.75 to -1.34)  .02  2508  -5.35 (-11.15 to 0.46)  -8.70 (-18.16 to 0.75)  .07  1747 
 BMI ≥ 40 kg/m2 17.7  -3.44 (-6.53 to -0.35)  -7.07 (-13.41 to -0.72)  .03  2508  -3.63 (-8.19 to 0.94)  -5.90 (-13.33 to 1.52)  .12  1747 
Glycosylated Hemoglobin (HbA1c) 
e
                           
 HbA1c 6.2  -0.09 (-0.22 to 0.04)  -0.18 (-0.44 to 0.08)  .18  2092  -0.09 (-0.26 to 0.09)  -0.14 (-0.41 to 0.13)  .32  1516 
 HbA1c ≥ 6.5% 20.0  -4.42 (-8.01 to -0.83)  -9.10 (-16.49 to -1.71)  .02  2092  0.31 (-4.90 to 5.52)  0.49 (-7.69 to 8.66)  .91  1516 
Linear regression, TOT calculated using instrumental variables (IV) 
f
                   
Body Mass Index (BMI) 
d 
                            
 BMI  32.9  -0.64 (-1.33 to 0.05)  -1.31 (-2.73 to 0.11)  .07  2508  -0.43 (-1.53 to 0.68)  -0.69 (-2.48 to 1.10)  .45  1747 
 BMI ≥ 30 kg/m2 58.6  -1.19 (-5.43 to 3.05)  -2.45 (-11.14 to 6.25)  .58  2508  -0.18 (-6.36 to 6.01)  -0.29 (-10.34 to 9.77)  .96  1747 
 BMI ≥ 35 kg/m2 35.5  -4.65 (-8.65 to -0.65)  -9.53 (-17.77 to -1.30)  .02  2508  -5.35 (-11.15 to 0.46)  -8.70 (-18.14 to 0.75)  .07  1747 
 BMI ≥ 40 kg/m2 17.7  -3.44 (-6.53 to -0.35)  -7.06 (-13.40 to -0.72)  .03  2508  -3.63 (-8.19 to 0.94)  -5.90 (-13.33 to 1.54)  .12  1747 
Glycosylated Hemoglobin (HbA1c) 
e
                           
 HbA1c 6.2  -0.09 (-0.22 to 0.04)  -0.18 (-0.44 to 0.08)  .18  2092  -0.09 (-0.26 to 0.09)  -0.14 (-0.41 to 0.13)  .32  1516 
 HbA1c ≥ 6.5% 20.0  -4.42 (-8.01 to -0.83)  -8.99 (-16.34 to -1.64)  .02  2092  0.31 (-4.90 to 5.52)  0.49 (-7.69 to 8.66)  .91  1516 
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Supplemental Table 3. continued 
a
 The analysis sample consists of female adults with valid BMI (for the BMI measures) or valid HbA1c (for the HbA1c measures) in the long-term follow-up data collection. For the 
low-poverty voucher comparison, the number of observations denotes the total number of women included in the analyses from both the control and low-poverty voucher groups.  
For the traditional voucher comparison, the number of observations denotes the total number of women included in the analyses from both the control and traditional voucher groups. 
b
 Intention to treat (ITT) estimates compare average outcomes of everyone assigned to treatment group with average outcomes of controls, adjusting for the set of baseline covariates 
shown in Table 1 and indicators for survey sample release and random assignment periods. Impacts from logistic regression presented as average marginal effects. 
c
 Treatment on the Treated (TOT) estimate is intended to capture the change in the outcome/mediator associated with MTO-assisted moves among those who actually moved with 
MTO vouchers. It is estimated by dividing the treatment group’s ITT effect by the share of the group that complies with the treatment, which is equivalent to using random 
assignment as an instrumental variable for treatment group compliance. 
d
 BMI was calculated from measured height and weight for most adults (a small number self-reported) as part of the long-term follow-up data collection. 
e
 HbA1c was assayed from dried blood spots collected as part of the long-term follow-up data collection. 
f
 As above, the TOT estimate is intended to capture the change in the outcome/mediator associated with MTO-assisted moves among those who actually moved with MTO vouchers, 
but here it is calculated using two-stage least squares, in which the first stage uses linear regression to regress an indicator for using a MTO voucher against an indicator for 
assignment to one of the MTO treatment groups, together with the baseline covariates shown in Table 1. The second stage uses linear regression to regress the health outcomes 
reported in row labels at left against the same baseline covariates plus the predicted value of using a MTO voucher from the first stage; the indicator for assignment to one of the 
MTO treatment groups serves as the instrumental variable excluded from the second stage regression. See Angrist J, Imbens G, Rubin D. Identification of causal effects using 
instrumental variables. Journal of the American Statistical Association. 1996;91(434): 444-72. 
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Supplemental Table 4. Main Health Outcomes, Separately for Treatment Compliers (Moved with MTO Voucher) and Non-Compliers (Did Not Use MTO Voucher) 
a
 
  
Control 
 
Low-poverty housing voucher 
 
Traditional housing voucher 
   
Total mean 
 
Complier 
mean 
 
Non-
complier 
mean 
 
Total mean 
 
Complier 
mean 
 
Non-
complier 
mean 
  
No.
b
 (%)
b
 
 
No.
b
 (%)
b
 
 
No.
b
 (%)
b
 
 
No.
b
 (%)
b
 
 
No.
b
 (%)
b
 
 
No.
b
 (%)
b
 
 
No.
b
 (%)
b
 
                      Body Mass Index (BMI)
c
 (n = 1092) 
 
(n = 1416) 
 
(n = 696) 
 
(n = 720) 
 
(n = 655) 
 
(n = 396) 
 
(n = 259) 
 
                     
 Percent BMI ≥ 30 kg/m
2
 639 (58.6) 
 
827 (57.5) 
 
398 (57.0) 
 
429 (58.0) 
 
381 (58.4) 
 
227 (57.5) 
 
154 (59.9) 
 
                      Percent BMI ≥ 35 kg/m2 382 (35.5) 
 
456 (31.1) 
 
220 (31.5) 
 
236 (30.8) 
 
208 (30.8) 
 
123 (29.9) 
 
85 (32.3) 
 
                      Percent BMI ≥ 40 kg/m2 195 (17.7) 
 
212 (14.4) 
 
101 (14.0) 
 
111 (14.8) 
 
104 (15.4) 
 
64 (15.9) 
 
40 (14.5) 
  
                    Glycosylated Hemoglobin (HbA1c)d (n = 924) 
 
(n = 1168) 
 
(n = 575) 
 
(n = 593) 
 
(n = 592) 
 
(n = 363) 
 
(n = 229) 
 
                      Percent HbA1c ≥ 6.5% 175 (20.0) 
 
187 (16.3) 
 
86 (15.4) 
 
101 (17.1) 
 
123 (20.6) 
 
74 (20.3) 
 
49 (21.1) 
                      
a
 The analysis sample consists of female adults with valid BMI (for the BMI measures) or valid HbA1c (for the HbA1c measure) in the long-term follow-up data collection. 
b
 No. unweighted. % calculated using sample weights to account for changes in random assignment ratios across randomization cohorts and for subsample interviewing. 
c 
BMI was calculated from measured height and weight for most adults (a small number self-reported) as part of the long-term follow-up data collection. 
d 
HbA1c was assayed from dried blood spots collected as part of the long-term follow-up data collection. 
 
  
Supplemental Table 5. Association Between MTO Adult Baseline Characteristics and Likelihood of Using a MTO Voucher (Treatment Compliance)
a
  
   
Low-poverty housing voucher 
 
Traditional housing voucher 
   
Dependent variable = 1 if used MTO voucher, 
else = 0 
b
 
 
Dependent variable = 1 if used MTO voucher, 
else = 0 
b
 
   
(n = 1425) 
 
(n = 657) 
Explanatory Variable from Baseline Survey 
c,d
 Odds Ratio 
 
95% CI 
 
P Value 
 
Odds Ratio 
 
95% CI 
 
P Value 
Adult Characteristics 
               
 
Baseline age (reference category: age > 40) 
               
  
≤ 25 2.31 
 
(1.33 to 4.00) 
 
<.01 
 
2.94 
 
(1.29 to 6.69) 
 
.01 
  
26-30 1.84 
 
(1.11 to 3.07) 
 
.02 
 
2.68 
 
(1.28 to 5.61) 
 
<.01 
  
31-35 1.32 
 
(0.84 to 2.06) 
 
.23 
 
1.21 
 
(0.67 to 2.18) 
 
.54 
  
36-40 0.79 
 
(0.49 to 1.25) 
 
.31 
 
1.30 
 
(0.65 to 2.61) 
 
.46 
 
Race (reference category: white) 
            
 
  
  
African-American 0.49 
 
(0.26 to 0.94) 
 
.03 
 
0.80 
 
(0.29 to 2.21) 
 
.66 
  
Other non-white race 0.38 
 
(0.20 to 0.73) 
 
<.01 
 
1.00 
 
(0.41 to 2.45) 
 
1.00 
 
Hispanic ethnicity 0.95 
 
(0.54 to 1.67) 
 
.86 
 
1.23 
 
(0.60 to 2.52) 
 
.58 
 
Never married 1.03 
 
(0.76 to 1.41) 
 
.85 
 
0.53 
 
(0.32 to 0.87) 
 
.01 
 
Under age 18 at birth of first child 1.10 
 
(0.80 to 1.51) 
 
.56 
 
1.01 
 
(0.59 to 1.72) 
 
.98 
 
Working 1.21 
 
(0.86 to 1.69) 
 
.27 
 
1.97 
 
(1.13 to 3.44) 
 
.02 
 
Enrolled in school 1.68 
 
(1.18 to 2.40) 
 
<.01 
 
0.74 
 
(0.42 to 1.31) 
 
.31 
 
High school diploma 1.21 
 
(0.89 to 1.65) 
 
.22 
 
1.79 
 
(1.07 to 2.98) 
 
.03 
 
General Education Development (GED) 1.35 
 
(0.94 to 1.95) 
 
.11 
 
2.09 
 
(1.10 to 3.96) 
 
.02 
Household Characteristics           
 Female head of household 1.58  (0.83 to 3.03)  .17  0.97  (0.34 to 2.75)  .95 
 Household member disabled 0.92  (0.62 to 1.36)  .66  0.74  (0.40 to 1.34)  .31 
 Owns car 1.25  (0.84 to 1.84)  .27  1.43  (0.77 to 2.66)  .25 
 No teens in household 0.77  (0.55 to 1.09)  .14  1.28  (0.80 to 2.05)  .30 
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Supplemental Table 5. continued                 
 
  
   
  
 
   
Low-poverty housing voucher 
 
Traditional housing voucher 
   
Dependent variable = 1 if used MTO voucher, 
else = 0 
b
 
 
Dependent variable = 1 if used MTO voucher, 
else = 0 
b
 
   
(n = 1425) 
 
(n = 657) 
Explanatory Variable from Baseline Survey 
c,d
 Odds Ratio 
 
95% CI 
 
P Value 
 
Odds Ratio 
 
95% CI 
 
P Value 
Household Characteristics (continued)                
 
Household size (reference category: size > 4) 
    
 
       
 
  
  
Two 1.94 
 
(1.26 to 2.98) 
 
<.01 
 
1.87 
 
(0.94 to 3.72) 
 
.08 
  
Three 1.63 
 
(1.12 to 2.38) 
 
.01 
 
1.51 
 
(0.83 to 2.76) 
 
.18 
  
Four 1.31 
 
(0.90 to 1.91) 
 
.16 
 
1.78 
 
(0.98 to 3.23) 
 
.06 
Receiving Government Benefits 
    
 
 
 
     
 
  
 
Supplemental Security Income 
e
 0.88 
 
(0.60 to 1.29) 
 
.50 
 
1.07 
 
(0.60 to 1.92) 
 
.82 
 
Aid to Families with Dependent Children 1.08 
 
(0.68 to 1.71) 
 
.74 
 
1.76 
 
(0.90 to 3.44) 
 
.10 
 
Food Stamps 1.39 
 
(0.85 to 2.27) 
 
.19 
 
1.57 
 
(0.80 to 3.06) 
 
.19 
 
Women, Infants, and Children 1.16 
 
(0.87 to 1.56) 
 
.32 
 
1.35 
 
(0.83 to 2.18) 
 
.22 
 
Medicaid 0.87 
 
(0.62 to 1.21) 
 
.40 
 
1.00 
 
(0.58 to 1.73) 
 
1.00 
Over 30 Minutes Away from the… 
    
 
          
 
Grocery store 0.88 
 
(0.62 to 1.24) 
 
.46 
 
0.71 
 
(0.43 to 1.17) 
 
.18 
 
Doctor 0.93 
 
(0.70 to 1.24) 
 
.62 
 
0.99 
 
(0.66 to 1.48) 
 
.96 
Neighborhood Characteristics
 f
 
    
 
       
 
  
 
Household member was crime victim in past 6 months 1.30 
 
(0.99 to 1.71) 
 
.06 
 
1.08 
 
(0.68 to 1.69) 
 
.76 
 
Streets very unsafe at night 0.89 
 
(0.67 to 1.17) 
 
.40 
 
1.45 
 
(0.92 to 2.29) 
 
.11 
 
Very dissatisfied with neighborhood 1.47 
 
(1.10 to 1.96) 
 
<.01 
 
1.40 
 
(0.90 to 2.18) 
 
.14 
 
Very confident about finding new apartment 1.28 
 
(0.98 to 1.67) 
 
.07 
 
1.11 
 
(0.74 to 1.66) 
 
.61 
 
Lived in neighborhood 5 or more years 1.01 
 
(0.76 to 1.35) 
 
.94 
 
1.01 
 
(0.76 to 1.35) 
 
.94 
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Supplemental Table 5. continued                 
 
  
   
  
 
   
Low-poverty housing voucher 
 
Traditional housing voucher 
   
Dependent variable = 1 if used MTO voucher, 
else = 0 
b
 
 
Dependent variable = 1 if used MTO voucher, 
else = 0 
b
 
   
(n = 1425) 
 
(n = 657) 
Explanatory Variable from Baseline Survey 
c,d
 Odds Ratio 
 
95% CI 
 
P Value 
 
Odds Ratio 
 
95% CI 
 
P Value 
 
Moved more than 3 times in 5 years prior to baseline 1.01 
 
(0.62 to 1.65) 
 
.96 
 
1.02 
 
(0.48 to 2.18) 
 
.95 
 
Previously applied for Section 8 1.17 
 
(0.90 to 1.52) 
 
.25 
 
1.29 
 
(0.86 to 1.94) 
 
.23 
 
No family in neighborhood 0.95 
 
(0.72 to 1.25) 
 
.72 
 
1.28 
 
(0.82 to 1.98) 
 
.28 
 
No friends in neighborhood 1.09 
 
(0.82 to 1.44) 
 
.56 
 
1.28 
 
(0.83 to 1.96) 
 
.26 
 
Chatted with neighbors at least once per week 0.81 
 
(0.61 to 1.07) 
 
.13 
 
1.07 
 
(0.70 to 1.65) 
 
.75 
 
Very likely to tell neighbor about their child getting 
into trouble 0.78 
 
(0.60 to 1.01) 
 
.06 
 
1.24 
 
(0.81 to 1.90) 
 
.33 
Primary or secondary reason for moving was… 
    
 
          
 
To get away from drugs and gangs 1.43 
 
(1.01 to 2.04) 
 
.05 
 
0.93 
 
(0.54 to 1.59) 
 
.78 
 
Better schools for the children 1.07 
 
(0.76 to 1.50) 
 
.70 
 
1.04 
 
(0.61 to 1.76) 
 
.89 
 
To get a bigger or better apartment 1.10 
 
(0.77 to 1.57) 
 
.61 
 
1.06 
 
(0.62 to 1.82) 
 
.84 
 
To get a job 0.98 
 
(0.55 to 1.74) 
 
.94 
 
0.85 
 
(0.31 to 2.38) 
 
.76 
Site (reference category: New York) 
    
 
 
 
        
 
Baltimore 1.39 
 
(0.82 to 2.35) 
 
.23 
 
9.09 
 
(2.67 to 30.96) 
 
<.01 
 
Boston 0.98 
 
(0.58 to 1.65) 
 
.94 
 
3.32 
 
(1.35 to 8.18) 
 
<.01 
 
Chicago 0.28 
 
(0.16 to 0.48) 
 
<.01 
 
5.08 
 
(2.15 to 12.05) 
 
<.01 
 
Los Angeles 1.51 
 
(0.86 to 2.64) 
 
.15 
 
2.57 
 
(1.24 to 5.32) 
 
.01 
Site/Randomization Cohort 
    
 
       
 
  
 
Baltimore Cohort 2 (reference category: Cohort 1) 0.38 
 
(0.17 to 0.82) 
 
.01 
 
0.36 
 
(0.11 to 1.24) 
 
.11 
 
Boston (reference category: Cohort 1) 
    
 
       
 
  
  
Cohort 3 0.40 
 
(0.20 to 0.82) 
 
.01 
 
0.38 
 
(0.14 to 0.98) 
 
.05 
  
Cohort 7 0.65 
 
(0.31 to 1.36) 
 
.25 
 
0.13 
 
(0.03 to 0.48) 
 
<.01 
25 
 
       
 
       
 
  Supplemental Table 5. continued                 
 
  
   
  
 
   
Low-poverty housing voucher 
 
Traditional housing voucher 
   
Dependent variable = 1 if used MTO voucher, 
else = 0 
b
 
 
Dependent variable = 1 if used MTO voucher, 
else = 0 
b
 
   
(n = 1425) 
 
(n = 657) 
Explanatory Variable from Baseline Survey 
c,d
 Odds Ratio 
 
95% CI 
 
P Value 
 
Odds Ratio 
 
95% CI 
 
P Value 
Site/Randomization Cohort (continued) 
    
 
       
 
  
 
Chicago (reference category: Cohort 1) 
    
 
       
 
  
  
Cohort 6 2.02 
 
(1.16 to 3.49) 
 
.01 
 
1.50 
 
(0.41 to 5.54) 
 
.54 
  
Cohort 8 1.84 
 
(0.81 to 4.16) 
 
.15 
 
0.30 
 
(0.10 to 0.85) 
 
.02 
 
Los Angeles (reference category: Cohort 4) 
    
 
       
 
  
  
Cohort 1 1.38 
 
(0.71 to 2.68) 
 
.35 
 
5.13 
 
(1.01 to 26.03) 
 
.05 
  
Cohort 11 0.92 
 
(0.36 to 2.37) 
 
.87 
 
1.12 
 
(0.39 to 3.20) 
 
.83 
 
New York (reference category: Cohort 5) 
    
 
       
 
  
  
Cohort 1 0.84 
 
(0.49 to 1.42) 
 
.51 
 
0.96 
 
(0.40 to 2.29) 
 
.92 
  
Cohort 9 2.81 
 
(0.71 to 11.20) 
 
.14 
 
2.87 
 
(0.68 to 12.08) 
 
.15 
  
Cohort 10 1.61 
 
(0.45 to 5.85) 
 
.47 
 
0.32 
 
(0.03 to 3.07) 
 
.33 
a
 The analysis sample is female adults with valid Body Mass Index (BMI) or valid glycosylated hemoglobin (HbA1c). 
b
 The table shows results of a logistic regression with voucher use as the dependent variable, and each of the baseline characteristics shown at left. Two  
separate logistic regression models were estimated, one for adults assigned to the low-poverty voucher group and one for adults in the traditional voucher  
group. Sample weights to account for changes in random assignment ratios across randomization cohorts and for subsample interviewing were applied. 
c
 Unless otherwise noted, the reference category is the opposite of the row label (e.g. non-Hispanic is the reference category for Hispanic ethnicity). 
d
 A Wald test rejects the hypothesis that the baseline covariates are jointly equal to zero when predicting whether the adult used the MTO voucher (i.e., treatment 
compliance) for both the low-poverty and the traditional housing voucher group (p<.001 in both cases). 
e
 Supplemental Security Income (SSI) is a federal assistance program for aged, blind, and disabled people. 
f
 The baseline head of household reported on the neighborhood characteristics listed here. 
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Supplemental Table 6. Association of MTO Randomized Intervention with Main Health Outcomes and Neighborhood Characteristics, Separately for MTO Adults Above vs. 
Below Sample’s Median Age at Baseline (33)a 
    Low-poverty housing voucher vs. control group  Traditional housing voucher vs. control group 
  Control 
Mean 
 
Intention to Treat 
[ITT]
b
 (95% CI) 
 Treatment on the 
Treated 
[TOT]
c
  (95% CI) 
 
P 
Value  N 
 
Intention to Treat 
[ITT]
b
 (95% CI)  
Treatment on the 
Treated 
[TOT]
c
  (95% CI) 
 
P 
Value  N 
                               
Body Mass Index (BMI) ≥ 30 kg/m2 d                   
 < 33 years at baseline 57.7  2.30 (-3.42 to 8.03)  4.14 (-6.15 to 14.42)  .43  1368  -0.97 (-8.95 to 7.01)  -1.39 (-12.79 to 10.02)  .81  943 
 ≥ 33 years at baseline 59.7  -5.32 (-11.63 to 0.99)  -13.04 (-28.51 to 2.43)  .10  1140  0.60 (-7.69 to 8.90)  1.16 (-14.87 to 17.20)  .89  804 
Body Mass Index (BMI) ≥ 35 kg/m2 d                   
 < 33 years at baseline 38.1  -6.68 (-12.16 to -1.20)  -12.00 (-21.85 to -2.16)  .02  1368  -9.35 (-16.81 to -1.89)  -13.36 (-24.02 to -2.70)  .01  943 
 ≥ 33 years at baseline 32.4  -2.23 (-8.07 to 3.60)  -5.48 (-19.79 to 8.84)  .45  1140  -1.13 (-8.96 to 6.69)  -2.19 (-17.32 to 12.94)  .78  804 
Body Mass Index (BMI) ≥ 40 kg/m2 d                   
 < 33 years at baseline 19.6  -3.69 (-8.08 to 0.70)  -6.63 (-14.52 to 1.25)  .10  1368  -6.34 (-12.19 to -0.50)  -9.07 (-17.42 to -0.71)  .03  943 
 ≥ 33 years at baseline 15.5  -3.14 (-7.51 to 1.23)  -7.70 (-18.41 to 3.02)  .16  1140  -0.58 (-6.71 to 5.55)  -1.12 (-12.97 to 10.73)  .85  804 
Glycosylated Hemoglobin (HbA1c) ≥ 6.5% e                   
 < 33 years at baseline 13.0  -4.10 (-8.15 to -0.05)  -7.42 (-14.76 to -0.08)  .05  1149  -0.09 (-5.87 to 5.70)  -0.12 (-8.30 to 8.05)  .98  836 
 ≥ 33 years at baseline 29.0  -4.81 (-10.99 to 1.37)  -11.63 (-26.57 to 3.32)  .13  943  0.79 (-7.28 to 8.87)  1.44 (-13.19 to 16.06)  .85  680 
Duration-Weighted Average Percent Poor from Random Assignment through Long-Term Follow-up 
f
 
 < 33 years at baseline 39.6  -10.40 (-11.92 to -8.89)  -18.51 (-21.21 to -15.81) <.01  1309  -6.75 (-8.63 to -4.87)  -9.53 (-12.18 to -6.88)  <.01  903 
 ≥ 33 years at baseline 39.7  -7.67 (-9.31 to -6.03)  -19.31 (-23.44 to -15.18) <.01  1095  -5.23 (-7.18 to -3.29)  -10.33 (-14.17 to -6.48)  <.01  770 
Duration-Weighted Concentrated Disadvantage Index from Random Assignment through Long-Term Follow-up 
f
 
 < 33 years at baseline 1.9  -0.32 (-0.37 to -0.27)  -0.57 (-0.66 to -0.48)  <.01  1309  -0.20 (-0.27 to -0.14)  -0.28 (-0.37 to -0.19)  <.01  903 
 ≥ 33 years at baseline 1.8  -0.22 (-0.28 to -0.16)  -0.55 (-0.70 to -0.41)  <.01  1095  -0.16 (-0.24 to -0.09)  -0.32 (-0.46 to -0.18)  <.01  770 
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Supplemental Table 6. continued 
a
 The analysis sample consists of female adults in MTO with valid Body Mass Index (BMI) or valid glycosylated hemoglobin (HbA1c) in the long-term follow-up data 
collection, and the analysis sample for census tract characteristics is further limited to those who have valid address data at baseline, year 1, year 5, and year 10. A test for 
association between MTO random assignment and the main health outcomes was conducted by estimating models with interactions of baseline age and treatment assignment. No 
coefficients in those models were shown to be significantly different from zero at the 5% significance level. 
b
 Intention to treat (ITT) estimates compare average outcomes of everyone assigned to treatment group with average outcomes of controls, adjusting for the set of baseline 
covariates shown in Table 1 and indicators for survey sample release and random assignment periods. MTO impacts on continuous dependent variables are calculated using 
linear regression. MTO impacts on dichotomous dependent variables are calculated  using logistic regression and are presented as average marginal effects. 
c
 Treatment on the Treated is estimated by dividing the treatment group’s ITT effect by the share of the group that complies with the treatment, which is equivalent to using 
random assignment as an instrumental variable for treatment group compliance. 
d
 BMI was calculated from measured height and weight for most adults (a small number self-reported) as part of the long-term follow-up data collection. 
e
 HbA1c was assayed from dried blood spots collected as part of the long-term follow-up data collection. 
f
 Random assignment date ranged from 1994 to 1998, and long-term follow-up began in June 2008. Census tract characteristics are as of the time when the MTO family lived in 
the tract, calculated by interpolating tract poverty values using data from the 1990 and 2000 decennial censuses and the 2005-09 American Community Survey. Average 
duration-weighted census tract characteristics give more weight to tracts in which MTO families spent relatively more time during the study period. The concentrated 
disadvantage index is a weighted combination of census tract percent (1) poverty, (2) African-American, (3) on welfare, (4) unemployed, (5) female-headed family households, 
and (6) under age 18, with loading factors developed using 2000 Census tracts in Chicago by Sampson RJ, Sharkey P, Raudenbush SW. Durable effects of concentrated 
disadvantage on verbal ability of African-American children. Proceedings of the National Academy of Science. 2008;105:845-852. 
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Supplemental Table 7. Association of MTO Randomized Intervention with Main Health Outcomes and Neighborhood Characteristics, Separately by MTO Demonstration Site 
a
 
    Low-poverty housing voucher vs. control group  Traditional housing voucher vs. control group 
  
Control 
Mean 
 
Intention to Treat 
[ITT]
b
 (95% CI) 
 Treatment on the 
Treated 
[TOT]
c
  (95% CI) 
 
P 
Value  N 
 
Intention to Treat 
[ITT]
b
 (95% CI)  
Treatment on the 
Treated 
[TOT]
c
  (95% CI) 
 
P 
Value  N 
                               
Body Mass Index (BMI) ≥ 30 kg/m2 d                   
 Baltimore 53.0  4.25 (-7.25 to 15.74)  7.58 (-12.93 to 28.08)  .47  343  4.89 (-10.17 to 19.95)  6.28 (-13.05 to 25.61)  .52  242 
 Boston 51.5  0.40 (-9.25 to 10.06)  0.94 (-21.61 to 23.50)  .94  526  -1.62 (-13.45 to 10.20)  -2.98 (-24.66 to 18.71)  .79  379 
 Chicago 65.1  1.97 (-7.23 to 11.16)  5.99 (-21.99 to 33.96)  .68  542  -6.29 (-19.52 to 6.95)  -9.34 (-29.00 to 10.33)  .35  283 
 Los Angeles 61.0  -2.69 (-11.42 to 6.04)  -4.26 (-18.05 to 9.54)  .55  563  -0.28 (-11.27 to 10.71)  -0.40 (-15.99 to 15.19)  .96  428 
 New York 59.9  -6.99 (-15.95 to 1.98)  -14.28 (-32.60 to 4.04)  .13  534  3.52 (-7.36 to 14.40)  7.91 (-16.52 to 32.33)  .53  415 
Body Mass Index (BMI) ≥ 35 kg/m2 d                   
 Baltimore 34.8  -3.74 (-14.44 to 6.97)  -6.67 (-25.76 to 12.43)  .49  343  -3.23 (-17.20 to 10.74)  -4.15 (-22.08 to 13.79)  .65  242 
 Boston 25.7  0.89 (-7.30 to 9.08)  2.08 (-17.04 to 21.19)  .83  526  0.13 (-10.15 to 10.40)  0.23 (-18.61 to 19.07)  .98  379 
 Chicago 50.0  -11.08 (-20.73 to -1.44)  -33.73 (-63.09 to -4.37)  .02  542  -14.95 (-28.16 to -1.74)  -22.21 (-41.83 to -2.59)  .03  283 
 Los Angeles 35.4  -3.65 (-11.98 to 4.69)  -5.76 (-18.94 to 7.42)  .39  563  -10.73 (-20.94 to -0.51)  -15.22 (-29.71 to -0.72)  .04  428 
 New York 31.9  -5.37 (-13.69 to 2.96)  -10.97 (-27.97 to 6.04)  .21  534  1.60 (-8.71 to 11.92)  3.60 (-19.55 to 26.75)  .76  415 
Body Mass Index (BMI) ≥ 40 kg/m2 d                   
 Baltimore 19.3  -8.13 (-16.24 to -0.02)  -14.50 (-28.96 to -0.03)  .05  343  -2.15 (-13.12 to 8.82)  -2.76 (-16.84 to 11.32)  .70  242 
 Boston 10.7  0.64 (-5.22 to 6.50)  1.50 (-12.19 to 15.18)  .83  526  -1.54 (-8.77 to 5.69)  -2.83 (-16.08 to 10.42)  .68  379 
 Chicago 25.5  -4.10 (-12.20 to 4.00)  -12.47 (-37.13 to 12.18)  .32  542  -2.73 (-14.17 to 8.70)  -4.06 (-21.04 to 12.93)  .64  283 
 Los Angeles 18.3  -3.54 (-10.11 to 3.04)  -5.59 (-15.98 to 4.80)  .29  563  -11.24 (-18.67 to -3.80)  -15.94 (-26.50 to -5.39)  <.01  428 
 New York 15.7  -3.66 (-9.82 to 2.50)  -7.48 (-20.06 to 5.10)  .24  534  -0.54 (-8.33 to 7.24)  -1.22 (-18.70 to 16.26)  .89  415 
Glycosylated Hemoglobin (HbA1c) ≥ 6.5% e                   
 Baltimore 14.1  0.26 (-8.92 to 9.45)  0.47 (-15.90 to 16.84)  .96  295  8.54 (-3.90 to 20.98)  11.15 (-5.09 to 27.38)  .18  214 
 Boston 21.4  -7.52 (-14.84 to -0.21)  -17.30 (-34.12 to -0.48)  .04  451  -5.94 (-14.45 to 2.58)  -10.66 (-25.95 to 4.63)  .17  332 
 Chicago 20.4  -6.53 (-14.83 to 1.77)  -19.60 (-44.53 to 5.33)  .12  456  -0.09 (-11.45 to 11.27)  -0.12 (-15.71 to 15.48)  .99  247 
 Los Angeles 18.0  1.64 (-5.72 to 8.99)  2.61 (-9.14 to 14.36)  .66  468  1.76 (-7.44 to 10.96)  2.42 (-10.23 to 15.07)  .71  375 
 New York 23.8  -8.63 (-16.71 to -0.56)  -17.61 (-34.09 to -1.14)  .04  422  -0.25 (-10.31 to 9.80)  -0.54 (-22.17 to 21.08)  .96  348 
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Supplemental Table 7. continued 
    Low-poverty housing voucher vs. control group  Traditional housing voucher vs. control group 
 
 
Control 
Mean 
 
Intention to Treat 
[ITT]
b
 (95% CI) 
 Treatment on the 
Treated 
[TOT]
c
  (95% CI) 
 
P 
Value  N 
 
Intention to Treat 
[ITT]
b
 (95% CI)  
Treatment on the 
Treated 
[TOT]
c
  (95% CI) 
 
P 
Value  N 
                               
Duration-Weighted Average Percent Poor from Random Assignment through Long-Term Follow-up 
f
 
 Baltimore 35.2  -7.93 (-10.63 to -5.22)  -14.20 (-19.04 to -9.35)  <.01  336  -6.99 (-10.22 to -3.76)  -8.90 (-13.01 to -4.79)  <.01  235 
 Boston 31.9  -6.60 (-8.66 to -4.54)  -15.19 (-19.92 to -10.46) <.01  509  -4.02 (-6.64 to -1.40)  -7.24 (-11.96 to -2.52)  <.01  362 
 Chicago 44.0  -6.59 (-9.23 to -3.96)  -19.64 (-27.50 to -11.79) <.01  509  -4.43 (-7.80 to -1.05)  -6.72 (-11.83 to -1.60)  .01  269 
 Los Angeles 43.6  -13.26 (-16.06 to -10.47) -21.30 (-25.79 to -16.82) <.01  533  -10.57 (-13.41 to -7.73)  -14.68 (-18.63 to -10.74)  <.01  408 
 New York 41.4  -10.35 (-12.48 to -8.22)  -21.70 (-26.18 to -17.23) <.01  517  -4.92 (-7.22 to -2.61)  -11.28 (-16.57 to -6.00)  <.01  399 
Duration-Weighted Concentrated Disadvantage Index from Random Assignment through Long-Term Follow-up 
f
 
 Baltimore 1.98  -0.31 (-0.41 to -0.20)  -0.55 (-0.74 to -0.36)  <.01  336  -0.21 (-0.35 to -0.07)  -0.27 (-0.45 to -0.09)  <.01  235 
 Boston 1.47  -0.20 (-0.27 to -0.13)  -0.46 (-0.62 to -0.31)  <.01  509  -0.12 (-0.19 to -0.04)  -0.21 (-0.35 to -0.07)  <.01  362 
 Chicago 2.36  -0.21 (-0.30 to -0.11)  -0.61 (-0.89 to -0.34)  <.01  509  -0.13 (-0.25 to -0.01)  -0.20 (-0.38 to -0.02)  .03  269 
 Los Angeles 1.70  -0.45 (-0.55 to -0.35)  -0.72 (-0.88 to -0.56)  <.01  533  -0.34 (-0.44 to -0.24)  -0.48 (-0.62 to -0.34)  <.01  408 
 New York 1.77  -0.21 (-0.28 to -0.14)  -0.44 (-0.58 to -0.30)  <.01  517  -0.14 (-0.22 to -0.06)  -0.32 (-0.51 to -0.14)  <.01  399 
a
 The analysis sample consists of female adults in MTO with valid Body Mass Index (BMI) or valid glycosylated hemoglobin (HbA1c) in the long-term follow-up data collection, 
and the analysis sample for census tract characteristics is further limited to those who have valid address data at baseline, year 1, year 5, and year 10. A test for association between 
MTO random assignment and the main health outcomes was conducted by estimating models with interactions of demonstration site and treatment assignment. No coefficients in 
those models were shown to be significantly different from zero at the 5% significance level. 
b
 Intention to treat (ITT) estimates compare average outcomes of everyone assigned to treatment group with average outcomes of controls, adjusting for the set of baseline 
covariates shown in Table 1 and indicators for survey sample release and random assignment periods. MTO impacts on continuous dependent variables are calculated using linear 
regression. MTO impacts on dichotomous dependent variables are calculated  using logistic regression and are presented as average marginal effects. 
c
 Treatment on the Treated is estimated by dividing the treatment group’s ITT effect by the share of the group that complies with the treatment, which is equivalent to using random 
assignment as an instrumental variable for treatment  group compliance. 
d
 BMI was calculated from measured height and weight for most adults (a small number self-reported) as part of the long-term follow-up data collection. 
e
 HbA1c was assayed from dried blood spots collected as part of the long-term follow-up data collection. 
f
 Random assignment date ranged from 1994 to 1998, and long-term follow-up began in June 2008. Census tract characteristics are as of the time when the MTO family lived in the 
tract, calculated by interpolating tract poverty values using data from the 1990 and 2000 decennial censuses and the 2005-09 American Community Survey. Average duration-
weighted census tract characteristics give more weight to tracts in which MTO families spent relatively more time during the study period. The concentrated disadvantage index is 
a weighted combination of census tract percent (1) poverty, (2) African-American, (3) on welfare, (4) unemployed, (5) female-headed family households, and (6) under age 18, 
with loading factors developed using 2000 Census tracts in Chicago by Sampson RJ, Sharkey P, Raudenbush SW. Durable effects of concentrated disadvantage on verbal ability of 
African-American children. Proceedings of the National Academy of Science. 2008;105:845-852. 
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Supplemental Table 8. Control Group Characteristics at Baseline and City-Level Characteristics, by MTO Demonstration Site     
   
  Site 
a
 
    
Baltimore 
 
Boston 
 
Chicago 
 
Los Angeles 
 
New York 
             Control Group Household Characteristics 
 
(n = 152) 
 
(n = 248) 
 
(n = 179) 
 
(n = 296) 
 
(n = 229) 
 
Age (y) 
 
31.6 
 
33.5 
 
30.5 
 
32.8 
 
34.4 
 
Female headed households (%) 
 
100.0 
 
92.3 
 
98.1 
 
87.5 
 
93.6 
 
African-American (%) 
 
98.7 
 
38.6 
 
98.8 
 
58.5 
 
49.8 
 
Hispanic (%) 
 
2.5 
 
43.7 
 
0.7 
 
41.5 
 
50.0 
 
1990 Census tract poverty (%) 
 
52.9 
 
39.5 
 
70.9 
 
54.6 
 
47.8 
 
1990 Census tract concentrated disadvantage index (i)
b
 
 
2.362 
 
1.719 
 
3.312 
 
2.181 
 
2.081 
City Characteristics 
          
 
City-Level Crime & Socioeconomic Measures 
          
  
1994 FBI Part I violent crime rate per 100,000 residents 
c
 
 
2834.4 
 
1915.5 
 
2763.5 
 
2059.0 
 
1860.9 
  
1994 FBI Part I property crime rate per 100,000 residents 
c
 9717.8 
 
7618.5 
 
7314.9 
 
5781.0 
 
5365.1 
  
1990 Census poverty (%) 
 
21.9 
 
18.7 
 
21.6 
 
18.9 
 
19.3 
  
1990 Census concentrated disadvantage index (i)
b
 
 
1.433 
 
0.978 
 
1.205 
 
0.815 
 
1.027 
  
1990 Census concentrated disadvantage index excluding percent black (i)
b
 
 
0.938 
 
0.764 
 
0.879 
 
0.699 
 
0.787 
 
County-Level Health Measures 
          
  
2002 diagnosed diabetic (%) 
d
 
 
8.1 
 
5.7 
 
7.0 
 
8.9 
 
7.7 
  
2002 obese (%) 
d
 
 
21.9 
 
17.0 
 
20.4 
 
19.6 
 
21.0 
  
2002 fair or poor general health (%) 
d
 
 
17.3 
 
15.6 
 
15.5 
 
19.5 
 
20.1 
  
2004 physically inactive (%) 
e
 
 
27.1 
 
23.3 
 
23.0 
 
19.9 
 
30.2 
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Supplemental Table 8. continued                     
a
 Units in parentheses (y - years, % - percent, i - see footnote b). Sample weights were used to account for changes in random assignment ratios and subsample 
interviewing. The sample for control group means is female adults with valid Body Mass Index (BMI) or valid glycosylated hemoglobin (HbA1c). 
b
 The concentrated disadvantage index is a weighted combination of census tract percent (1) poverty, (2) African-American, (3) on welfare, (4) unemployed,  
(5) female-headed family households, and (6) under age 18, with loading factors developed using 2000 Census tracts in Chicago by Sampson RJ, Sharkey P, Raudenbush 
SW. Durable effects of concentrated disadvantage on verbal ability of African-American children. Proceedings of the National Academy of Science. 2008;105:845-852. 
c
 City-level crime rates come from the FBI’s Uniform Crime Report (UCR) system (http://www.ucrdatatool.gov). Because the Chicago Police Department does not 
report forcible rape rates to the UCR system, we imputed the violent crime rate (which is sum of the rate per 100,000 residents of four components: murder, robbery, 
aggravated assault, and forcible rape) for Chicago by multiplying the summed rate for the three known components for Chicago by the ratio of the true violent crime rate 
in the other four MTO sites to the summed rate excluding forcible rape. 
d
 County-level health measures of diabetes, obesity, and general health come from the Centers for Disease Control and Prevention’s 2002 Behavioral Risk Factor 
Surveillance System (BRFSS) available at http://www.cdc.gov/BRFSS/. Counties by site are: Baltimore-Baltimore City, Boston-Suffolk, Chicago-Cook, Los Angeles-
Los Angeles, and for New York, Queens County, because the BRFSS data was not available for Bronx County. 
e
 County-level physical inactivity data (Baltimore City, Suffolk, Cook, Los Angeles, and Bronx Counties) is from the Centers for Disease Control and Prevention’s 2004 
National Diabetes Surveillance System (http://www.cdc.gov/diabetes/statistics/index.htm). 
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Supplemental Table 9. Quasi-Experimental Estimates for Relationship between Specific Neighborhood Characteristics and Main Health Outcomes 
a
     
Dependent Variable 
 
Instrumented Explanatory Variable 
 
Neighborhood Percent 
Poor Averaged Over All 
Years (95% CI) 
b
 
  
P Value 
 
Neighborhood Percent 
Poor in Past Three 
Years (95% CI) 
b
 
  
P Value 
 
Neighborhood Percent 
Poor More than Three 
Years Ago (95% CI) 
b
 
  P 
Value 
 
Concentrated 
Disadvantage Index 
(95% CI) 
c
 
  P 
Value 
         
     
  
     
  
     
 Body Mass Index 
(BMI) ≥ 30 kg/m² d 
 
0.29 (-0.15 to 0.73) 
 
.20 
 
0.44 (-0.27 to 1.16) 
 
.22 
 
0.25 (-0.13 to 0.64) 
 
.20 
 
6.49 (-7.74 to 20.73) 
 
.37 
Body Mass Index 
(BMI) ≥ 35 kg/m² d 
 
0.62 (0.20 to 1.04) 
 
<0.01 
 
0.78 (0.10 to 1.46) 
 
.03 
 
0.56 (0.19 to 0.93) 
 
<.01 
 
18.59 (4.86 to 32.32) 
 
.01 
Body Mass Index 
(BMI) ≥ 40 kg/m² d 
 
0.43 (0.11 to 0.76) 
 
<0.01 
 
0.64 (0.12 to 1.16) 
 
.02 
 
0.38 (0.09 to 0.67) 
 
<.01 
 
14.27 (3.55 to 24.99) 
 
.01 
Glycosylated 
Hemoglobin 
e
 
(HbA1c) ≥ 6.5% 
 
0.32 (-0.07 to 0.70) 
 
0.11 
 
0.42 (-0.21 to 1.05) 
 
.19 
 
0.28 (-0.06 to 0.62) 
 
0.11 
 
8.16 (-4.53 to 20.84) 
 
.21 
a
 The table presents results from using quasi-experimental instrumental variables (IV) design from Kling JR, Liebman JB, Katz LF. Experimental Analysis of Neighborhood 
Effects. Econometrica. 2007;75(1): 83-119 that uses interactions of MTO treatment group and demonstration site as instrumental variables for the specific neighborhood 
characteristics shown above. Each entry in the table is estimated separately using equation (5) (see Discussion of Analytic Methods, part C), with a different outcome or 
mediator. City-level main effects are not presented because they are perfectly collinear with site-fixed effects. The entries shown in the table represent the estimated change in 
the percentage of people with the health outcome that is associated with a 1 percentage point change in neighborhood poverty or a 1-point change in the neighborhood 
disadvantage index. The analysis sample consists of female adults who have valid BMI or valid HbA1c data and valid address data at baseline and year 1, year 5, and year 10 in 
the MTO long-term follow-up data collection. 
b
 Neighborhood characteristics are as of the time when the MTO family lived in the census tract, calculated by interpolating tract characteristics data from the 1990 and  2000 
decennial censuses and the 2005-09 American Community Survey and duration-weighted to give more weight to tracts in which MTO families spent relatively more time 
during the study period. The sample sizes, with valid address data at baseline, year 1 post-random assignment, year 5 post-random assignment, and year 10 post-random 
assignment, for the BMI analysis is N=3003 and for the HbA1c analysis is N=2544. 
c
 The concentrated disadvantage index is a weighted combination of census tract percent (1) poverty, (2) African-American, (3) on welfare, (4) unemployed, (5) female-headed 
family households, and (6) under age 18, with loading factors developed using 2000 Census tracts in Chicago by Sampson RJ, Sharkey P, Raudenbush SW. Durable effects of 
concentrated disadvantage on verbal ability of African-American children. Proceedings of the National Academy of Science. 2008;105: 845-852. The sample sizes, with valid 
address data, for the BMI analysis is N=3003 and for the HbA1c analysis is N=2544. 
d
 BMI was calculated from measured height and weight for most adults (a small number self-reported) as part of the long-term follow-up data collection.
  
e
 HbA1c was assayed from dried blood spots collected as part of the long-term follow-up data collection. 
 
